您当前的位置：
首页 >
文章列表页 >
Risk analysis of drug-related medical insurance claim denials in healthcare institutions and exploration of pharmacist-led intervention model
更新时间：2026-07-28

    • Risk analysis of drug-related medical insurance claim denials in healthcare institutions and exploration of pharmacist-led intervention model

    • ZHONGGUO YAOFANG   Vol. 37, Issue 14, Pages: 1832-1837(2026)

    • DOI：10.6039/j.issn.1001-0408.2026.14.06    

      CLC： R95

    • Received：20 March 2026，

      Revised：2026-07-15，

      Accepted：15 July 2026，

      Online First：24 July 2026，

      Published：30 July 2026

    移动端阅览

  • WANG Xiaolan,PAN Jie,GE Yi,et al.Risk analysis of drug-related medical insurance claim denials in healthcare institutions and exploration of pharmacist-led intervention model[J].ZHONGGUO YAOFANG,2026,37(14):1832-1837. DOI： 10.6039/j.issn.1001-0408.2026.14.06.

  •  
  •  

0

Views

1

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

药学干预对中药注射剂合理使用的影响分析
我院丙氨酰谷氨酰胺合理使用评价标准的制订及干预效果分析
DRGs-PPS下的临床药师参与股骨颈骨折临床路径的实施效果
Study on the feasibility of pharmaceutical intervention to improve medication appropriateness in elderly inpatients
Study on the influencing factors of venetoclax trough concentration and its association with efficacy in patients with acute myeloid leukemia

Related Author

LI Shengyan
SU Qiuping
LI Lianmao
CHEN Zhihui
LIU Kexin
LIANG Maozhi
HAN Fengzhao
LI Zhenzhi

Related Institution

No data
0